Liberty Health Sciences (OTCMKTS:LHSIF) Stock Price Down 2.2% – Should You Sell?

Shares of Liberty Health Sciences Inc. (OTCMKTS:LHSIFGet Free Report) fell 2.2% on Tuesday . The company traded as low as $1.10 and last traded at $1.1446. 671,400 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Stock Performance

The stock’s fifty day moving average is $1.14 and its two-hundred day moving average is $1.14. The firm has a market cap of $392.01 million, a price-to-earnings ratio of 38.17 and a beta of 1.70.

Liberty Health Sciences Company Profile

(Get Free Report)

Liberty Health Sciences, trading on the OTC Markets under the symbol LHSIF, is a vertically integrated medical cannabis company headquartered in Florida. The company holds state‐issued Medical Marijuana Treatment Center licenses that authorize cultivation, processing and retail operations within Florida’s regulated medical marijuana program. Its state‐of‐the‐art cultivation facilities feature controlled indoor and greenhouse environments designed to produce consistent, high‐quality flower and derivative products.

Liberty Health Sciences markets its products under the Sunshine Cannabis Co brand, offering a range of cannabis formulations that include dried flower, pre-rolled joints, concentrates, oils, capsules and topical preparations.

See Also

Receive News & Ratings for Liberty Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.